Physician-Assessed Peptide-Based Treatment
Peptide-based products are subject to UAE regulatory requirements that depend on their classification, intended use and authorization status. Where a peptide-based medicine requires marketing authorization, the applicable authorization must be in place before it is marketed or supplied for its intended use in the UAE.
At Novomed in Dubai & Abu Dhabi, peptide-based treatment is not a menu item you choose from. It begins with a consultation with a licensed physician who assesses whether a peptide-based treatment is clinically appropriate for you — and may conclude that another treatment or no pharmacological treatment is more appropriate. That clinical assessment is an important part of the service we provide.
What Is Peptide Therapy?
Peptides are short chains of amino acids that can act as signalling molecules in the body, interacting with specific receptors and biological pathways. Peptide therapy refers to the medical use of a specific peptide-based product for an appropriate clinical indication. Peptide products differ in their regulatory status, approved or permitted uses, dosing, evidence base and risk profile. For this reason, there is no single treatment called “peptide therapy” that can be described, priced or recommended in general terms. What applies to one peptide-based medicine does not necessarily apply to another. At Novomed, whether peptide-based treatment is appropriate for you is determined through individual clinical assessment rather than by selecting a compound from a catalogue.
How Does Peptide Therapy Work?
Peptides can interact with specific receptors and signalling pathways in the body. The way a particular peptide works and its clinical effects depend on the individual product and its intended medical use.
Peptides do not all act in the same way, and findings relating to one product should not automatically be generalized to other peptide products. Where a peptide-based medicine is considered appropriate, your physician will explain its mechanism, expected benefits, potential risks and side effects, available alternatives, current evidence and relevant regulatory information before treatment begins.
The route of administration, dose, treatment schedule and monitoring requirements depend on the specific product and your individual clinical assessment.
UAE Regulatory Requirements for Peptide-Based Products
Peptide-based products are subject to applicable UAE regulatory requirements relating to product classification, authorization, supply and clinical use. The Emirates Drug Establishment (EDE) provides the UAE regulatory framework for classification and applicable marketing authorization of medical products. EDE states that product classification determines the regulatory category and whether marketing authorization is required. Where authorization is required, the product must meet the applicable EDE requirements.
In Dubai, healthcare facilities and healthcare professionals are also subject to Dubai Health Authority licensing, standards, policies and regulatory requirements within their respective scopes.
At Novomed, treatment decisions are made by appropriately licensed healthcare professionals following an individual clinical assessment and within the applicable UAE regulatory framework.
Why Novomed Does Not Use Research-Grade or Unverified Compounds
Some peptide compounds available through online wellness markets or social media are marketed for research use rather than as medicines authorized for human therapeutic use. Patients should not assume that a product sold online or labelled “research use only” is suitable, safe or authorized for clinical treatment.
Novomed does not purchase, accept or administer peptide products obtained from unverified websites, social media accounts, individual sellers or suppliers whose regulatory status, source, identity or product documentation cannot be established. Where treatment is considered, the product’s regulatory status, clinical suitability, source and relevant documentation are assessed as part of responsible medical practice.
Peptide Therapy Process at Novomed
1. Consultation and Medical History
You meet a licensed physician who takes a detailed medical history, including your current medications and supplements, previous treatments and the specific concern that brought you to Novomed.
2. Clinical Examination and Investigations
Where clinically indicated, your physician may perform a physical examination and request laboratory investigations or other diagnostic assessments.
These assessments help establish your current clinical picture and identify potential contraindications, interactions or other factors that may affect treatment.
3. Clinical Decision
Your physician determines whether:
- a peptide-based medicine is clinically appropriate;
- another treatment is more appropriate;
- further investigation is required; or
- no pharmacological treatment is warranted.
Any of these may be an appropriate clinical outcome.
4. Informed Consent
If treatment is indicated, your physician explains the expected benefits, potential risks and side effects, alternatives, available evidence and relevant treatment information before obtaining your consent.
5. Follow-Up and Review
Treatment is reviewed at appropriate intervals. Your physician may continue, adjust or discontinue treatment depending on your clinical response and safety.
Intravenous Fluids and Infusions
The same medical-assessment principle applies to intravenous therapy.
Intravenous fluids, injections and infusions at Novomed are provided where there is a documented medical indication and a clear treatment plan based on clinical assessment. They are not presented as general-purpose treatments for detoxification, energy, recovery or wellness without an appropriate medical indication.
Peptide Consultation and Assessment Fees in Dubai & Abu Dhabi
Fees cover the medical assessment. Where a medicine is prescribed, its cost depends on the specific product and is quoted after the consultation.
| Service | Fee |
|---|---|
| Initial physician consultation | AED 300–800* |
| Laboratory investigations, where indicated | Quoted after consultation |
Novomed does not sell peptide programs, outcome-based packages or treatment bundles. Fees are based on clinical time and investigations.
Is Peptide Therapy Right for You?
A consultation may be appropriate if you have a specific medical concern that you would like assessed by a licensed physician. It is not intended for patients who simply want to obtain a particular compound they have seen online or on social media.
Your physician may conclude that peptide-based treatment is not appropriate for you. Another treatment, further investigation or no pharmacological treatment may instead be recommended.
Book a Peptide Consultation in Dubai & Abu Dhabi
To have your medical concern assessed by a licensed physician at Novomed in Dubai, Abu Dhabi or Al Ain, request an appointment below. Your physician will assess your individual circumstances and explain the appropriate treatment options within the applicable UAE medical and regulatory framework.
